15.83
0.00 (0.00%)
| Penutupan Terdahulu | 15.83 |
| Buka | 16.00 |
| Jumlah Dagangan | 187,049 |
| Purata Dagangan (3B) | 166,421 |
| Modal Pasaran | 266,394,176 |
| Harga / Jualan (P/S) | 3.35 |
| Harga / Buku (P/B) | 2.03 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Nov 2025 |
| Margin Keuntungan | -115.91% |
| Margin Operasi (TTM) | -61.41% |
| EPS Cair (TTM) | -3.81 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 169.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.20% |
| Nisbah Semasa (MRQ) | 2.07 |
| Aliran Tunai Operasi (OCF TTM) | -28.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.90 M |
| Pulangan Atas Aset (ROA TTM) | -14.52% |
| Pulangan Atas Ekuiti (ROE TTM) | -28.48% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Menaik |
| Diagnostics & Research (Global) | Menaik | Menaik | |
| Stok | Prenetics Global Limited | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.63 |
|
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 19.88% |
| % Dimiliki oleh Institusi | 12.57% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Prudential Plc | 30 Sep 2025 | 427,963 |
| Stevens Capital Partners | 30 Sep 2025 | 17,382 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |